Ann: OLE Study update reveals impressive Survival Data, page-126

I hold few pharma shares (DXB, IMU, PAA, NEU, MSB was sold a month ago to get more DXB ) for sometime, my best performer recently is DXB and worst is IMU, however with recent ODD designation and MT returning to the board, I trust my most successful stock in long run to be PAA.

Considering the unmet need to treat and cure MND, potential market size and ground-breaking p-value recently released, superiority of MLS to any drugs in the market, and time frame required to receive fast track approval to commercialise MLS (ODD approval with recent p-value could be just few weeks), the success is inevitable but will require a great deal of patience but I'm 100% confident it will take over SP of DXB in no time and much earlier than expected. If MLS study will be expanded to Dementia and Alzheimer, and becomes successful, it could be life changing just holding few hundreds K shares.

When I compare PAA with DXB, in last October the SP of DXB was 6C and now today 57C, however in the interim PAA overtook DXB and reached 53C, (DXB was trading around high 20C) and watching to get in to PAA. I got in recently when board tumultuous panic was introduced and ODD designation was announced) and now I'm very much relaxed to watch how future unfolds. Happy to accumulate if a pull back happens.